Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066)-Reference-Cited by-同舟云学术

Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066)

Published:2016-01 Issue:1 Volume:32 Page:32-43
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Hendrix Craig W.¹,Andrade Adriana¹,Bumpus Namandjé N.¹,Kashuba Angela D.²,Marzinke Mark A.¹,Moore Ayana³,Anderson Peter L.⁴,Bushman Lane R.⁴,Fuchs Edward J.¹,Wiggins Ilene¹,Radebaugh Christine¹,Prince Heather A.²,Bakshi Rahul P.¹,Wang Ruili²,Richardson Paul¹,Shieh Eugenie¹,McKinstry Laura⁵,Li Xin⁵,Donnell Deborah⁵,Elharrar Vanessa⁶,Mayer Kenneth H.⁷,Patterson Kristine B.²

Affiliation:

1. Johns Hopkins University, Baltimore, Maryland.

2. University of North Carolina-Chapel Hill, Chapel Hill, North Carolina.

3. FHI 360, Durham, North Carolina.

4. University of Colorado, Denver, Colorado.

5. SCHARP, Seattle, Washington.

6. National Institutes of Health Division of AIDS, Rockville, Maryland.

7. Fenway Health, Boston, Massachusetts.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology